METHOTREXATE
Active substance: methotrexate
INJECTION, SOLUTION · METHOTREXATE SODIUM 250 mg/10mL
United StatesActive
Marketing holder: Eugia US LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- METHOTREXATE SODIUM · 250 mg/10mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 42 |
|
| EU 2 |
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-7f3e-71b5-9804-59d29fa02114,01a1208c-7f40-7555-9b2f-06fc243385aa,01a1208c-8726-772f-adc7-46bf9220219a,01a1208c-8733-71d7-a156-89989fc78e29,01a1208c-c6ba-747a-9c2f-d623a935ef71;count=76 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 55150-513
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Sources
- product · openFDA NDC · 55150-513 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 55150-513 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 55150-513 · Verified 2026-10-09 · open in source